Cargando…

Disparate Effects of Atorvastatin Compared With Simvastatin on C-Reactive Protein Concentrations in Patients With Type 2 Diabetes

OBJECTIVE: Reduction in LDL and high sensitivity (hs) C-reactive protein (CRP) are independent indicators of successful cardiovascular risk reduction with statins. This study compared the effect of equivalent LDL-lowering doses of simvastatin and atorvastatin on hsCRP in type 2 diabetic patients. RE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sathyapalan, Thozhukat, Atkin, Stephen L., Kilpatrick, Eric S.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928339/ https://www.ncbi.nlm.nih.gov/pubmed/20805273 http://dx.doi.org/10.2337/dc10-0201

Ejemplares similares

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
por: Konya, Judit, et al.
Publicado: (2019)

Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
por: Paseban, Maryam, et al.
Publicado: (2019)

The Effect of High Dose Isoflavone Supplementation on Serum Reverse T(3) in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2019)

Soy Protein Improves Cardiovascular Risk in Subclinical Hypothyroidism: A Randomized Double-Blinded Crossover Study
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
por: Masadeh, Majed, et al.
Publicado: (2012)

Diagnostic and Prognostic Protein Biomarkers of β-Cell Function in Type 2 Diabetes and Their Modulation with Glucose Normalization
por: Moin, Abu Saleh Md, et al.
Publicado: (2022)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Plasma heat shock protein response to euglycemia in type 2 diabetes
por: Atkin, Alexander S, et al.
Publicado: (2021)

Atorvastatin and simvastatin as analgesic agents in experimental models
por: Dwajani, S., et al.
Publicado: (2012)

Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

The Effect of Phytoestrogen on Thyroid in Subclinical Hypothyroidism: Randomized, Double Blind, Crossover Study
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Angiopoietin-1: an early biomarker of diabetic nephropathy?
por: Butler, Alexandra E., et al.
Publicado: (2021)

The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects
por: Al-Qaissi, Ahmed, et al.
Publicado: (2019)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

ODP141 Complement Activation and Homeostasis Works Primarily Through the Alternative Pathway in Polycystic Ovary Syndrome
por: Atkin, Stephen, et al.
Publicado: (2022)

Potential Biomarkers to Predict Acute Ischemic Stroke in Type 2 Diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

The Effect of a Simulated Commercial Flight Environment with Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants with Type 2 Diabetes – A Cross-over Study
por: Konya, Judit, et al.
Publicado: (2018)

SAT366 Expression of Amyloid-related Proteins Associated With Dementia in Polycystic Ovary Syndrome Compared to a Control Population
por: Butler, Alexandra E, et al.
Publicado: (2023)

Corrigendum: The Effect of a Simulated Commercial Flight Environment With Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants With Type 2 Diabetes – A Cross-Over Study
por: Konya, Judit, et al.
Publicado: (2018)

Letter to the Editor: Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Hypoglycemia-induced changes in complement pathways in type 2 diabetes
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
por: Alexandre, Pedro CB, et al.
Publicado: (2013)

Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin
por: Jaiswal, Swapnil R., et al.
Publicado: (2012)

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2015)

Effects of Growth Hormone Replacement on Peripheral Muscle and Exercise Capacity in Severe Growth Hormone Deficiency
por: Gonzalez, Susana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_46qtgfrqeq28fql4fd64p4omsa